Viewing Study NCT03004105

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:14 AM
Ignite Modification Date: 2026-01-12 @ 5:31 AM
Study NCT ID: NCT03004105
Status: WITHDRAWN
Last Update Posted: 2018-03-16
First Post: 2016-12-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: MEDI4736 With Selumetinib for KRAS Mutant Non-Small Cell Lung Cancer (NSCLC)
Sponsor: M.D. Anderson Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma View
None Advanced Lung Cancer View
None Recurrent Nonsmall Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Malignant Neoplasm of Respiratory and Intrathoracic Organ Carcinoma View
None Advanced Lung Cancer View
None Recurrent Nonsmall Cell Lung Cancer View
None Selumetinib View
None AZD6244 View
None Durvalumab View
None MEDI4736 View